Neogenomics stockNEO
Neogenomics trades at $16.49, 18.2% below its 52-week high (Oct 6, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +40.2% year to date, +58.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 23, 2027.
Ratings, candles, signals and the screener for NEO — after you log in
Open the terminalFrequently asked questions about Neogenomics
What is the Neogenomics stock price?
At the close on Nov 5, 2026: $16.49 (−3.85% on the day). 52-week high: $20.15 on Oct 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Neogenomics report earnings?
The next quarterly report is on Feb 23, 2027. Last quarter, earnings per share changed +133% year over year, revenue +11%.
Does Neogenomics pay dividends?
No, Neogenomics does not pay dividends.
Where does Neogenomics trade and how to buy it?
Ticker NEO, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Neogenomics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NEO are in the terminal after you log in.